Aliases & Classifications for Presbyopia

MalaCards integrated aliases for Presbyopia:

Name: Presbyopia 12 74 43 15 62 71 32

Classifications:



External Ids:

Disease Ontology 12 DOID:11638
ICD9CM 34 367.4
MeSH 43 D011305
SNOMED-CT 67 41256004
ICD10 32 H52.4
UMLS 71 C0033075

Summaries for Presbyopia

PubMed Health : 62 About presbyopia: It happens to all of us eventually: You have to start holding newspapers or books further away in order to be able to read them and clearly recognize letters without straining your eyes. Seeing nearby objects less clearly is a normal part of aging. Known as presbyopia, this typically becomes noticeable in your mid-forties. Although there are no effective treatments for the causes of presbyopia, the effects can be corrected. The best and easiest way to do so is using reading glasses.

MalaCards based summary : Presbyopia is related to cycloplegia and astigmatism, and has symptoms including aniseikonia An important gene associated with Presbyopia is CRYAA (Crystallin Alpha A). The drugs Dipivefrin and Vitamins have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and endothelial.

Wikipedia : 74 Presbyopia is a condition associated with the aging of the eye that results in progressively worsening... more...

Related Diseases for Presbyopia

Diseases related to Presbyopia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 70)
# Related Disease Score Top Affiliating Genes
1 cycloplegia 32.7 IFITM2 CTSC
2 astigmatism 31.5 TRARG1 IFITM2 CRYAA
3 corneal ectasia 31.0 TRARG1 IFITM2
4 anisometropia 30.8 TRARG1 IFITM2 CTSC
5 irregular astigmatism 30.7 TRARG1 IFITM2
6 cataract 30.5 MIP FOXE3 CRYGS CRYAA BFSP2 BFSP1
7 senile cataract 29.9 LAMA3 CRYGS CRYAA BFSP1
8 refractive error 11.9
9 farsightedness 11.8
10 myopia 10.8
11 eye disease 10.4
12 ocular motor apraxia 10.4
13 cataract 44 10.3 MIP CRYAA
14 disuse amblyopia 10.3 FOXE3 CRYAA
15 nuclear senile cataract 10.3 LAMA3 CRYGS
16 retinal perforation 10.3 CRYGS CRYAA
17 cataract 31, multiple types 10.3 CRYAA BFSP1
18 axenfeld-rieger syndrome, type 1 10.3 FOXE3 CRYAA
19 sclerocornea 10.2 FOXE3 CRYAA
20 strabismus 10.2
21 aging 10.2
22 mechanical strabismus 10.2
23 blood group, globoside system 10.2 LAMA3 CRYAA
24 juvenile glaucoma 10.2 FOXE3 CRYAA
25 galactokinase deficiency 10.2 CRYGS CRYAA
26 early-onset sutural cataract 10.2 MIP CRYGS BFSP2
27 early-onset nuclear cataract 10.2 MIP CRYAA BFSP1
28 diabetic cataract 10.2 CRYGS CRYAA
29 nance-horan syndrome 10.2 CRYAA BFSP2 BFSP1
30 glaucoma, primary open angle 10.1
31 laryngoonychocutaneous syndrome 10.1
32 yemenite deaf-blind hypopigmentation syndrome 10.1
33 myopia 6 10.1
34 microvascular complications of diabetes 5 10.1
35 monocular esotropia 10.1
36 open-angle glaucoma 10.1
37 alternating exotropia 10.1
38 exotropia 10.1
39 ocular hypertension 10.1
40 esotropia 10.1
41 aniridia 1 10.1 FOXE3 CRYAA BFSP2
42 endophthalmitis 10.1 LAMA3 CRYAA
43 early-onset lamellar cataract 10.1 MIP CRYGS CRYAA BFSP2
44 mature cataract 10.0 MIP LAMA3 CRYGS CRYAA
45 lens subluxation 10.0 CRYAA BFSP1
46 corneal disease 10.0 TRARG1 IFITM2 FOXE3 CRYAA
47 posterior polar cataract 10.0 CRYGS CRYAA BFSP2 BFSP1
48 corneal dystrophy, fuchs endothelial, 1 10.0
49 ocular dominance 10.0
50 polykaryocytosis inducer 10.0

Graphical network of the top 20 diseases related to Presbyopia:



Diseases related to Presbyopia

Symptoms & Phenotypes for Presbyopia

UMLS symptoms related to Presbyopia:


aniseikonia

Drugs & Therapeutics for Presbyopia

PubMed Health treatment related to Presbyopia: 62

Although there are no effective treatments to fight the cause of presbyopia , the effects of presbyopia are easily corrected. The easiest way to solve the problem of not being able to see nearby objects is wearing ready-made reading glasses available in shops. But these readily available reading glasses don't account for possible differences in vision between your eyes or other features, such as astigmatism (an irregularly shaped cornea ). Individually adjusted prescription reading glasses are only available from an optician's, where glasses with the required lens power are made especially based on the results of an eye test. The distance between the pupils of your eyes and other factors are also taken into account. Reading glasses are often narrow enough for you to be able to look over them if you want to see things that are further away. If you already wore prescription glasses before presbyopia started becoming an issue, multifocals are an option. Bifocal glasses (bifocals) are one type of multifocal glasses. They have two zones divided in the middle by a visible horizontal line. The lower half of the glasses is for looking at nearby objects, and the upper half is for looking at objects that are further away. Trifocals have a visibly separate third zone for seeing objects at intermediate distances too. In varifocals (also known as progressive lenses ), the lines dividing the different zones have been smoothly polished so you can’t see them. They are the most common kind of glasses.

Drugs for Presbyopia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 51)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dipivefrin Approved Phase 4 52365-63-6 3105
2 Vitamins Phase 4
3 Omega 3 Fatty Acid Phase 4
4 Anti-Bacterial Agents Phase 4
5 Alkylating Agents Phase 4
6 Antibiotics, Antitubercular Phase 4
7 Mitomycins Phase 4
8 Pharmaceutical Solutions Phase 3
9 Ophthalmic Solutions Phase 3
10
Tropicamide Approved, Investigational Phase 2 1508-75-4 5593
11
Choline Approved, Nutraceutical Phase 2 62-49-7 305
12 Hypolipidemic Agents Phase 2
13 Gastrointestinal Agents Phase 2
14 Nootropic Agents Phase 2
15 Alpha-lipoic Acid Phase 2
16 Lipid Regulating Agents Phase 2
17 Antimetabolites Phase 2
18 Thioctic Acid Phase 2
19
Hydrogen peroxide Approved, Vet_approved 7722-84-1 784
20
Salicylic acid Approved, Investigational, Vet_approved 69-72-7 338
21
Miconazole Approved, Investigational, Vet_approved 22916-47-8 4189
22
Hyaluronic acid Approved, Vet_approved 9004-61-9 53477741
23
Pilocarpine Approved, Investigational Early Phase 1 92-13-7, 54-71-7 5910
24
Dopamine Approved 51-61-6, 62-31-7 681
25
Methamphetamine Approved, Illicit 537-46-2 10836
26
Meclocycline Investigational 2013-58-3 5480760
27 Anti-Infective Agents, Local
28 Disinfectants
29 Anti-Infective Agents
30 Contact Lens Solutions
31 Dermatologic Agents
32 Antifungal Agents
33 Keratolytic Agents
34 Anesthetics
35 Central Nervous System Depressants
36 Tea
37 Tetrahydrozoline
38 Muscarinic Agonists Early Phase 1
39 Cholinergic Agents Early Phase 1
40 Adrenergic Agonists Early Phase 1
41 Antihypertensive Agents Early Phase 1
42 Adrenergic alpha-2 Receptor Agonists Early Phase 1
43 Brimonidine Tartrate Early Phase 1 70359-46-5
44 Polymethyl Methacrylate
45 Neurotransmitter Agents
46 Sympathomimetics
47 Dopamine Uptake Inhibitors
48 Central Nervous System Stimulants
49 Dopamine Agents
50 Autonomic Agents

Interventional clinical trials:

(show top 50) (show all 179)
# Name Status NCT ID Phase Drugs
1 A Prospective Safety and Effectiveness Study of a New High Repetition Rate Excimer Laser Using LASIK for the Correction of Ammetropia and Presbyopia Unknown status NCT02112968 Phase 4
2 A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIK Unknown status NCT01977807 Phase 4
3 PHASE IV STUDY # 1162. Prospective Investigation of SUPRACOR Visual Outcomes of Presbyopic Hyperopic Patients With and Without Astigmatism Unknown status NCT01628146 Phase 4
4 A Randomized, Subject-masked Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting IOLs Completed NCT01166971 Phase 4
5 A Randomized, Subject-masked Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting IOLs Completed NCT00963560 Phase 4
6 Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle Independence With Bilateral Implantation of the Tecnis Multifocal (TMF) Intraocular Lens or Crystalens AO (CAO) Intraocular Lens Completed NCT01275118 Phase 4
7 A Prospective Study to Evaluate the Safety and Effectiveness of the Supracor Presbyopic Treatment Algorithm for Pseudophakic Eyes Using Lasik Completed NCT01387360 Phase 4
8 Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular Lenses Completed NCT01061281 Phase 4
9 Clinical Evaluation of the Biofinity Multifocal Lens Compared With the Air Optix Aqua Multifocal Lens and With PureVision Multifocal Lens (INNOVATION PRESBYOPIA Study) Completed NCT01591499 Phase 4
10 Visual Performance After Implantation of an Aspheric Multifocal Diffractive Intraocular Lens Completed NCT01065064 Phase 4
11 A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopes Treated With Mitomycin C During Surgery and Extended Steroid After Surgery Recruiting NCT03242317 Phase 4 Mitomycin C
12 A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopes Implanted Under a Corneal Flap or Within a Small-Incision Pocket Recruiting NCT03376412 Phase 4
13 A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopic Patients With Treatments to Optimize the Ocular Surface Before Implantation Recruiting NCT03126877 Phase 4 Mitomycin C
14 A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopes Implanted in Corneal Pockets With a Delayed or Non-Delayed Approach Suspended NCT03326869 Phase 4
15 A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation. Terminated NCT03101501 Phase 4 Mitomycin c
16 Evaluation of the Safety & Efficacy of the LaserACE® Procedure to Restore Visual Function and Range of Accommodation Unknown status NCT01491360 Phase 3
17 A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc., RAINDROP® NEAR VISION INLAY for the Improvement of Near and Intermediate Vision in Pseudophakic Subjects Unknown status NCT02668523 Phase 3
18 Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes Unknown status NCT02110472 Phase 3
19 A Prospective Study To Evaluate The Safety And Effectiveness Of The SUPRACOR Presbyopic Treatment Algorithm For Myopia And Myopic Astigmatism Using LASIK Unknown status NCT01404884 Phase 3
20 Intrastromal Correction of Ametropia by a Femtosecond Laser Unknown status NCT00928122 Phase 3
21 A Prospective Multicenter, Study to Evaluate the Safety and Effectiveness of the Presbyopia Algorithm for Hyperopia and Hyperopic Astigmatism Using LASIK Completed NCT00910403 Phase 3
22 Intrastromal Presbyopia Correction by Means of a Femtosecond Laser Completed NCT01025050 Phase 3
23 A Prospective Study to Evaluate the Safety and Effectiveness of the Presbyopic LASIK Algorithm Completed NCT01322919 Phase 3
24 Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of AGN-190584 in Participants With Presbyopia Recruiting NCT03804268 Phase 3 AGN-190584;Vehicle
25 A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of AGN-190584 in Participants With Presbyopia Active, not recruiting NCT03857542 Phase 3 AGN-190584
26 Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens Active, not recruiting NCT02487160 Phase 3
27 Randomized Clinical Trial of Bifocal Lenses Versus Computer-specific Progressive Addition Lenses on Symptoms and Performance on a Computer Terminated NCT00585026 Phase 3
28 A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia Completed NCT03201562 Phase 2 PRX-100;PRX-100 Component #1;PRX-100 Vehicle
29 Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia Completed NCT02197806 Phase 2 AGN-199201;AGN-190584;AGN-199201 Vehicle
30 A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 (Aceclidine/Tropicamide) Ophthalmic Topical Formulation in the Treatment of Early to Moderate Presbyopia Completed NCT02554396 Phase 2 PRX-100;Placebo
31 A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia Completed NCT02780115 Phase 2 AGN-199201 ophthalmic solution;AGN-190584 ophthalmic solution;AGN-199201 Vehicle;AGN-190584 Vehicle
32 A Phase 2, Multicenter, Double-masked, Randomized, Vehicle-Controlled, Study of the Concurrent Use of AGN-190584 and AGN-199201 in Patients With Presbyopia Completed NCT02595528 Phase 2 AGN-199201 ophthalmic solution;AGN-190584 ophthalmic solution;AGN-190584 vehicle;AGN-199201 + AGN-190584 Combination;AGN-199201 vehicle
33 A Phase 2a, Double-Masked, Randomized, Placebo-Controlled, Single-Administration Study to Establish Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects Completed NCT02965664 Phase 2 PresbiDrops (CSF-1);Placebo
34 A Phase 2a, Double-blind, Randomized, Placebo-controlled, Repeated Administration, Crossover Study to Establish Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects Completed NCT02745223 Phase 2 PresbiDrops (CSF-1);Placebo
35 A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia Completed NCT02516306 Phase 1, Phase 2 EV06 Ophthalmic Solution;Placebo Ophthalmic Solution
36 A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia Completed NCT03885011 Phase 2 CSF-1;CSF-1 Component #1;CSF-1 Component #2
37 A 3-month, Randomized, Placebo-controlled, Double-masked, Multi-center Study to Evaluate the Safety and Efficacy of Topical Ocular UNR844-Cl in Subjects With Presbyopia Recruiting NCT03809611 Phase 2 UNR844-Cl;Placebo
38 Functional and Physiological Changes Induced by Pinhole Glasses in Presbyopia Unknown status NCT02722291
39 Presbyopia Compensation: Looking for Electrophysiological Predictors Unknown status NCT02444130
40 Clinical Performance Evaluation of a Progressive Addition Lens Among Presbyopic Patients Unknown status NCT01443585
41 The Effect of Cataract Extraction on the Contractility of Ciliary Muscle Unknown status NCT00624039
42 Visual Function, Non-dependence on Glasses and Global Economic Cost in Patients Undergoing Lens Surgery With ReSTOR® Multifocal Aspheric Iol Implants Unknown status NCT01088282
43 Retrospective Functional Assessment of Activities of Daily Living (ADL) in Patients Who Underwent Bilateral Implantation of Aspheric Bifocal Intraocular Lenses or Aspheric Trifocal Intraocular Lenses Unknown status NCT03021512
44 Retrospective Functional Assessment of Activities of Daily Living (ADL) in Patients Who Underwent Mini-monovision Correction With Bilateral Implantation of Aspheric Monofocal Intraocular Lenses Unknown status NCT02431156
45 Study to Evaluate the Safety and Efficacy of HI-BRITE Large Diameter Rigid Gas Permeable Contact Lens (Hexafocon b) Test When Worn on a Daily Wear Basis in the Correction of Myopia/Hyperopia/Astigmatism/Presbyopia/ and Irregular Cornea. Unknown status NCT02812316
46 Mix and Match Study of Two Multifocal Intraocular Lens With Different Add Power Unknown status NCT02556944
47 High-resolution Imaging of Tear Film Thickness in Contact Lenses Wearers With Optical Coherence Tomography (OCT). A Pilot Study Unknown status NCT02713399
48 A 180 Day, Multicenter Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses for Daily Wear Use in the Correction of Refractive Error With or Without Astigmatism in Non-diseased Eyes Unknown status NCT01058629
49 Development of a Validated Chart for Intermediate Vision Assessment Unknown status NCT02279446
50 Safety and Efficacy of Implantation of Two Multifocal Intraocular Lenses in the Treatment of Senile Cataract: a Randomized Controlled Clinical Trial Unknown status NCT02966496

Search NIH Clinical Center for Presbyopia

Cochrane evidence based reviews: presbyopia

Genetic Tests for Presbyopia

Anatomical Context for Presbyopia

MalaCards organs/tissues related to Presbyopia:

40
Eye, Testes, Endothelial, Breast, Thymus, Brain, Cortex

Publications for Presbyopia

Articles related to Presbyopia:

(show top 50) (show all 1299)
# Title Authors PMID Year
1
Long-term Outcomes After LASIK Using a Hybrid Bi-aspheric Micro-monovision Ablation Profile for Presbyopia Correction. 61
32032429 2020
2
How much astigmatism to treat in cataract surgery. 61
31770161 2020
3
Correction of presbyopia: old problems with old (and new) solutions. 61
31734940 2020
4
Model of the light sword intraocular lens: in-vitro comparative studies. 61
32010498 2020
5
The Effect of Ocular Demodex Colonization on Schirmer test and OSDI Scores in Newly Diagnosed Dry Eye Patients. 61
31393313 2020
6
Ambient assisted living technologies for older adults with cognitive and physical impairments: a review. 61
31841201 2019
7
Laser asymmetric ablation method to improve corneal shape. 61
30903527 2019
8
Clinical outcomes of a novel presbyopia-correcting soft contact lens with a small aperture. 61
31882253 2019
9
Population-based study on the epidemiology of dry eye disease and its association with presbyopia and other risk factors. 61
31359236 2019
10
Pharmacological Strategies for Presbyopia Correction. 61
31830297 2019
11
Thirty Year Projected Magnitude (to 2050) of Near and Distance Vision Impairment and the Economic Impact if Existing Solutions are Implemented Globally. 61
31810404 2019
12
Implantation of Presbyopia-Correcting Intraocular Lenses Staged After Descemet Membrane Endothelial Keratoplasty in Patients With Fuchs Dystrophy. 61
31842037 2019
13
Amplitude of Accommodation in Patients with Multiple Sclerosis. 61
31172825 2019
14
Factors That Influence the Success of Contact Lens Fitting in Presbyopes: A Multicentric Survey. 61
31008825 2019
15
[Presbyopia Correction with Intraocular Lenses]. 61
31745941 2019
16
Defocus curves of 4 presbyopia-correcting IOL designs: Diffractive panfocal, diffractive trifocal, segmental refractive, and extended-depth-of-focus. 61
31706517 2019
17
Observational Clinical Studies of Human Lens Transparency Using the Vision Index Pen. 61
31772825 2019
18
Pre-operative simulation of post-operative multifocal vision. 61
31799048 2019
19
Histopathologic Analysis of Explanted KAMRA Corneal Inlays Demonstrating Adherent Fibroconnective Tissue Scar Formation. 61
31768368 2019
20
Assessing a modified fitting approach for improved multifocal contact lens fitting. 61
31253425 2019
21
Which intraocular lens would ophthalmologists choose for themselves? 61
31089237 2019
22
Stromal keratophakia: Corneal inlay implantation. 61
31493488 2019
23
[Presbyopia and refractive surgery]. 61
30857805 2019
24
Presbyopia and Other Eye Conditions in Teachers in Ghana. 61
31484296 2019
25
Presbyopia Correction Using Multifocal Soft Contact Lenses in Patients With Monofocal Intraocular Lenses. 61
31517737 2019
26
Influence of presbyopia on smartphone usage among Chinese adults: A population study. 61
31090978 2019
27
Lens Stretching Modulates Lens Epithelial Cell Proliferation via YAP Regulation. 61
31546253 2019
28
Refractive and Visual Outcomes of SUPRACOR TENEO 317 LASIK for Presbyopia in Hyperopic Eyes: 24-Month Follow-up. 61
31498417 2019
29
Prevalence of Refractive Error, Presbyopia, and Spectacle Coverage in Bogotá, Colombia: A Rapid Assessment of Refractive Error. 61
31318796 2019
30
Presbyopia and the aging eye: Existing refractive approaches and their potential impact on dry eye signs and symptoms. 61
31445772 2019
31
Visual Function after Implantation of a Presbyopia-Correcting Trifocal Intraocular Lens. 61
31390634 2019
32
Monovision and the Misperception of Motion. 61
31353183 2019
33
A 3-year follow-up study of a new corneal inlay: clinical results and outcomes. 61
31446390 2019
34
Presbyopia management with Q-factor modulation without additive monovision: One-year visual and refractive results. 61
31126780 2019
35
Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections. 61
31462416 2019
36
Small-aperture strategies for the correction of presbyopia. 61
31033734 2019
37
Unilateral Refractive Lens Exchange with a Multifocal Intraocular Lens in Emmetropic Presbyopic Patients. 61
30841762 2019
38
Prevalence, pattern and factors associated with ocular disorders in small-scale welders in Katwe, Kampala. 61
31291941 2019
39
Varifocal Versus Monofocal LASIK in Presbyopic Hyperopic Eyes. 61
31298726 2019
40
AcrySof IQ PanOptix Intraocular Lens Versus Extended Depth of Focus Intraocular Lens and Trifocal Intraocular Lens: A Clinical Overview. 61
31403494 2019
41
In vivo assessment of the mechanical properties of crystalline lenses in a rabbit model using ultrasound elastography: Effects of ultrasound frequency and age. 61
31077713 2019
42
Ocular and orbital side effects of ALK inhibitors: a review article. 61
31140869 2019
43
A Modified Syringe Plunger Device Significantly Reduces Guidewire Threading Time Regardless of Experience Level or the Presence of Presbyopia. 61
31006303 2019
44
Autofocals: Evaluating gaze-contingent eyeglasses for presbyopes. 61
31259239 2019
45
Outcomes of presbyopia-correcting intraocular lenses after laser in situ keratomileusis. 61
29594789 2019
46
Refractive surgery. 61
31106754 2019
47
Prevalence of refractive errors, uncorrected refractive error, and presbyopia in adults in India: A systematic review. 61
31007213 2019
48
Visual quality after presbyopia correction with excimer laser ablation using micromonovision and modulation of spherical aberration. 61
30713017 2019
49
Adaptive eyeglasses for presbyopia correction: an original variable-focus technology. 61
31052911 2019
50
Presbyopia and Glaucoma: Two Diseases, One Pathophysiology? The 2017 Friedenwald Lecture. 61
31038661 2019

Variations for Presbyopia

Expression for Presbyopia

Search GEO for disease gene expression data for Presbyopia.

Pathways for Presbyopia

GO Terms for Presbyopia

Biological processes related to Presbyopia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell maturation GO:0048469 9.26 BFSP2 BFSP1
2 visual perception GO:0007601 9.26 MIP CRYGS CRYAA BFSP2
3 lens fiber cell development GO:0070307 9.16 BFSP2 BFSP1
4 lens development in camera-type eye GO:0002088 8.8 MIP FOXE3 CRYGS

Molecular functions related to Presbyopia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 structural constituent of eye lens GO:0005212 9.02 MIP CRYGS CRYAA BFSP2 BFSP1

Sources for Presbyopia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....